Antifibrinolytics use during surgery for oncological spine diseases: A systematic review.

Avila, Mauricio J; Orenday-Barraza, José Manuel; Cavagnaro, María José; Strouse, Isabel M; Farhadi, Dara S; Khan, Naushaba; Hussein, Amna; Baaj, Ali A

Avila, Mauricio J; Orenday-Barraza, José Manuel; Cavagnaro, María José; Strouse, Isabel M; Farhadi, Dara S; Khan, Naushaba; Hussein, Amna; Baaj, Ali A.

Afiliação

Avila MJ; Department of Neurosurgery, University of Arizona, Tucson, United States.
Orenday-Barraza JM; Department of Neurosurgery, University of Arizona College of Medicine, Phoenix, Arizona, United States.
Cavagnaro MJ; Department of Neurosurgery, University of Arizona, Tucson, United States.
Strouse IM; Department of Neurosurgery, University of Arizona College of Medicine, Phoenix, Arizona, United States.
Farhadi DS; Department of Neurosurgery, University of Arizona College of Medicine, Phoenix, Arizona, United States.
Khan N; Department of Neurosurgery, University of Arizona College of Medicine, Phoenix, Arizona, United States.
Hussein A; Department of Neurosurgery, University of Arizona College of Medicine, Phoenix, Arizona, United States.
Baaj AA; Department of Neurosurgery, University of Arizona College of Medicine, Phoenix, Arizona, United States.

Surg Neurol Int ; 13: 567, 2022.

Article em En | MEDLINE | ID: mdl-36600747

Palavras-chave

Antifibrinolytics; Metastatic spine disease; Spine oncology; Spine surgery; Tranexamic acid

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Surg Neurol Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google